The role of a dihydromorphanthridine derivative in Parkinson's patients treated with L-dopa. A preliminary report.
D000978:Antiparkinson Agents / Q000627:therapeutic use*; D003984:Dibenzazepines / Q000627:therapeutic use*; D004295:Dihydroxyphenylalanine / Q000627:therapeutic use*; D004123:Dimethylamines / Q000627:therapeutic use; D006801:Humans; D010300:Parkinson Disease / Q000188:drug therapy*; D014202:Tremor / Q000188:drug therapy
D000978:Antiparkinson Agents; D003984:Dibenzazepines; D004123:Dimethylamines; D004295:Dihydroxyphenylalanine